Melatonin Synergizes BRAF-targeting Agent Vemurafenib in Melanoma Treatment by Inhibiting iNOS/hTERT Signaling and Cancer-Stem Cell Traits
Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-019-1036-z
Full Text
Open PDFAbstract
Available in full text
Date
February 4, 2019
Authors
Publisher
Springer Science and Business Media LLC